Data from EMC - Curated by Toby Galbraith - Last updated 04 April 2017

Licensing authority

EMA (European Medicines Agency)

Indication(s)

Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Type 2 Diabetes

View the latest epidemiology data, patient perspectives, ADA and EASD recommendations, treatment options and more

Visit Type 2 Diabetes


Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

Visit Acute and Advanced Heart Failure


Related Content

More information

Category Value
Agency product number EMEA/H/C/002835
Orphan designation No
Date First Approved 09-09-2014
Type POM
Marketing authorisation holder Eli Lilly Regional Operations GmbH
Warnings This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions